{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:34:25Z","timestamp":1757608465182,"version":"3.44.0"},"reference-count":59,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2017,2,4]]},"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>Many drugs are given to intubated neonates by the inhalation route. The optimum aerosol delivery system, however, has not been identified and there are many challenges in delivering drugs effectively to the lower airways of intubated neonates. The effectiveness of surfactant in prematurely born infants and nitric oxide has been robustly investigated. Other drugs are being used on very limited evidence.<\/jats:p>","DOI":"10.1136\/archdischild-2016-311711","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T20:50:16Z","timestamp":1488919816000},"page":"F277-F281","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["The roles of drug therapy given via the endotracheal tube to neonates"],"prefix":"10.1136","volume":"102","author":[{"given":"Anne","family":"Greenough","sequence":"first","affiliation":[{"name":"Division of Asthma, Allergy and Lung Biology, MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK"},{"name":"NIHR Biomedical Research Centre at Guy's and St Thomas\u2019 NHS Foundation Trust and King's College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niovi","family":"Papalexopoulou","sequence":"additional","affiliation":[{"name":"Division of Asthma, Allergy and Lung Biology, MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"2025090222065260000_102.3.F277.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-010-1292-6"},{"key":"2025090222065260000_102.3.F277.2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11095-014-1466-4","article-title":"Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilation","volume":"32","author":"Longest","year":"2015","journal-title":"Pharm Res"},{"key":"2025090222065260000_102.3.F277.3","first-page":"646","article-title":"Special problems in aerosol delivery: neonatal and paediatric considerations","volume":"45","author":"Cole","year":"2000","journal-title":"Respir Care"},{"key":"2025090222065260000_102.3.F277.4","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P"},{"key":"2025090222065260000_102.3.F277.5","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.8.659"},{"key":"2025090222065260000_102.3.F277.6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.siny.2010.03.007","article-title":"Long term consequences of oxygen therapy in the neonatal period","volume":"15","author":"Jobe","year":"2010","journal-title":"Sem Fetal Neonatal Med"},{"key":"2025090222065260000_102.3.F277.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.3.677"},{"key":"2025090222065260000_102.3.F277.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa023080"},{"key":"2025090222065260000_102.3.F277.9","doi-asserted-by":"crossref","unstructured":"Askie LM , Henderson-Smart DJ , Ko H . Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev 2009;(1):CD001077. doi:10.1002\/14651858.CD001077.pub2","DOI":"10.1002\/14651858.CD001077.pub2"},{"key":"2025090222065260000_102.3.F277.10","doi-asserted-by":"publisher","DOI":"10.1159\/000356561"},{"key":"2025090222065260000_102.3.F277.11","doi-asserted-by":"crossref","unstructured":"Rojas-Reyes M , Morley CJ , Soll R . Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012;(3):CD000510. doi:10.1002\/14651858.CD000510.pub2","DOI":"10.1002\/14651858.CD000510.pub2"},{"key":"2025090222065260000_102.3.F277.12","doi-asserted-by":"crossref","unstructured":"Bahadue FL , Soll R . Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2012;(11):CD001456. doi:10.1002\/14651858.CD001456.pub2","DOI":"10.1002\/14651858.CD001456.pub2"},{"key":"2025090222065260000_102.3.F277.13","doi-asserted-by":"crossref","unstructured":"Seger N , Soll R . Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009;(2):CD007836. doi:10.1002\/14651858.CD007836","DOI":"10.1002\/14651858.CD007836"},{"key":"2025090222065260000_102.3.F277.14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3443"},{"key":"2025090222065260000_102.3.F277.15","doi-asserted-by":"publisher","DOI":"10.1159\/000349928"},{"key":"2025090222065260000_102.3.F277.16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.2016.10708","article-title":"Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis","volume":"316","author":"Isayama","year":"2016","journal-title":"JAMA"},{"key":"2025090222065260000_102.3.F277.17","doi-asserted-by":"crossref","unstructured":"Finer NN , Barrington KJ . Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006;(4):CD000399. doi:10.1002\/14651858.CD000399.pub2","DOI":"10.1002\/14651858.CD000399.pub2"},{"key":"2025090222065260000_102.3.F277.18","doi-asserted-by":"crossref","unstructured":"Barrington KJ , Finer N . Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2010;(12):CD000509. doi:10.1002\/14651858.CD000509.pub4","DOI":"10.1002\/14651858.CD000509.pub4"},{"key":"2025090222065260000_102.3.F277.19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-2725"},{"key":"2025090222065260000_102.3.F277.20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2015.11.050","article-title":"Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension","volume":"170","author":"Kinsella","year":"2016","journal-title":"J Pediatr"},{"key":"2025090222065260000_102.3.F277.21","first-page":"45","article-title":"Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices","volume":"9","author":"Cosa","year":"2016","journal-title":"Med Devices (Auckl)"},{"key":"2025090222065260000_102.3.F277.22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-0033-1348949","article-title":"Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension","volume":"31","author":"Yilmaz","year":"2014","journal-title":"Am J Perinatol"},{"key":"2025090222065260000_102.3.F277.23","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.94835"},{"key":"2025090222065260000_102.3.F277.24","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22985"},{"key":"2025090222065260000_102.3.F277.25","doi-asserted-by":"crossref","unstructured":"Shah SS , Ohlsson A , Halliday HL , et al . Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database Syst Rev 2012;(5):CD002057. doi:10.1002\/14651858.CD002057.pub3","DOI":"10.1002\/14651858.CD002057.pub3"},{"key":"2025090222065260000_102.3.F277.26","doi-asserted-by":"crossref","unstructured":"Onland W , Offringa M , van Kaam A . Late (\u22657\u2005days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev 2012;(4):CD002311. doi:10.1002\/14651858.CD002311.pub3","DOI":"10.1002\/14651858.CD002311.pub3"},{"key":"2025090222065260000_102.3.F277.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501917"},{"key":"2025090222065260000_102.3.F277.28","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMe1509243","article-title":"No End to Uncertainty about Inhaled Glucocorticoids in Preterm Infants","volume":"373","author":"Schmidt","year":"2015","journal-title":"N Engl J Med"},{"key":"2025090222065260000_102.3.F277.29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1973"},{"key":"2025090222065260000_102.3.F277.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.10.049"},{"key":"2025090222065260000_102.3.F277.31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201505-0861OC"},{"key":"2025090222065260000_102.3.F277.32","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fml018"},{"key":"2025090222065260000_102.3.F277.33","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmm035"},{"key":"2025090222065260000_102.3.F277.34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/14767058.2014.985202","article-title":"The role of early inhaled budesonide therapy in meconium aspiration in term newborns: a randomized control study","volume":"29","author":"Garg","year":"2016","journal-title":"J Maternal Fetal Neonatal Med"},{"key":"2025090222065260000_102.3.F277.35","doi-asserted-by":"publisher","DOI":"10.1203\/01.pdr.0000219388.56608.77"},{"key":"2025090222065260000_102.3.F277.36","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000156371.89952.35"},{"key":"2025090222065260000_102.3.F277.37","first-page":"CD008308","article-title":"Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome","volume":"5","author":"Abdel-Latif","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090222065260000_102.3.F277.38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/14767050600736754","article-title":"Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study","volume":"19","author":"Lauterbach","year":"2006","journal-title":"J Maternal Fetal Neonatal Med"},{"key":"2025090222065260000_102.3.F277.39","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.3.469"},{"key":"2025090222065260000_102.3.F277.40","doi-asserted-by":"crossref","unstructured":"Ng GY , Da S , Ohlsson A . Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev 2001;(3):CD003214. doi:10.1002\/14651858.CD003214","DOI":"10.1002\/14651858.CD003214"},{"key":"2025090222065260000_102.3.F277.41","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050969"},{"key":"2025090222065260000_102.3.F277.42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13052-016-0215-1","article-title":"Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial","volume":"42","author":"Dehdashtian","year":"2016","journal-title":"Ital J Pediatr"},{"key":"2025090222065260000_102.3.F277.43","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.141"},{"key":"2025090222065260000_102.3.F277.44","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22750"},{"key":"2025090222065260000_102.3.F277.45","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21324"},{"key":"2025090222065260000_102.3.F277.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2010.03245.x."},{"key":"2025090222065260000_102.3.F277.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2011.03519.x."},{"key":"2025090222065260000_102.3.F277.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1992.tb12238.x"},{"key":"2025090222065260000_102.3.F277.49","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-303988"},{"key":"2025090222065260000_102.3.F277.50","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0937"},{"key":"2025090222065260000_102.3.F277.51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000327531","article-title":"Use of heliox in the management of neonates with meconium aspiration syndrome","volume":"100","author":"Szczapa","year":"2011","journal-title":"Neonatology"},{"key":"2025090222065260000_102.3.F277.52","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0787"},{"key":"2025090222065260000_102.3.F277.53","doi-asserted-by":"crossref","unstructured":"Azzopardi D , Robertson NJ , Bainbridge A , et al . Moderate hypothermia within 6\u2005h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial. Lancet Neurol 2015. doi:10.1016\/S1474-4422(15)00347-6","DOI":"10.1016\/S1474-4422(15)00347-6"},{"key":"2025090222065260000_102.3.F277.54","unstructured":"ClinicalTrials.gov. Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth (CoolXenon3). NCT02071394; 2015."},{"key":"2025090222065260000_102.3.F277.55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200902-0179OC"},{"key":"2025090222065260000_102.3.F277.56","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/pr.2015.39","article-title":"Combined iNO and endothelial progenitor cells improve lung alveolar and vascular structure in neonatal rats exposed to prolonged hyperoxia","volume":"77","author":"Lu","year":"2015","journal-title":"Pediatr Res"},{"key":"2025090222065260000_102.3.F277.57","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00347.2011"},{"key":"2025090222065260000_102.3.F277.58","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial","volume":"164","author":"Chang","year":"2014","journal-title":"J Pediatr"},{"key":"2025090222065260000_102.3.F277.59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047559"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2016-311711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:07:06Z","timestamp":1756876026000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2016-311711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,4,19]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1136\/archdischild-2016-311711"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2016-311711","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"type":"print","value":"1359-2998"},{"type":"electronic","value":"1468-2052"}],"subject":[],"published":{"date-parts":[[2017,3,7]]}}}